EQS-News

    137 Aufrufe 137 0 Kommentare 0 Kommentare

    Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board

    Für Sie zusammengefasst
    • Epigenomics AG appoints Hansjörg Plaggemars to Executive Board
    • Plaggemars has over 20 years of management experience in finance
    • Supervisory Board is pleased with Plaggemars' expertise and experience

    EQS-News: Epigenomics AG / Key word(s): Personnel
    Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board

    31.01.2024 / 15:30 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board

    Berlin, January 31, 2024 - Epigenomics AG (Frankfurt General Standard: ECX; the "Company"), a holding company focusing on investments in the field of minimally invasive blood tests for cancer detection, announces that the Supervisory Board has appointed Mr. Hansjörg Plaggemars to the Executive Board effective February 1, 2024.

    Hansjörg Plaggemars (53) has more than 20 years of management experience in finance in various European companies.

    He started his career at KPMG Corporate Finance and has worked as a CFO for over 14 years in various industries, including software, retail, prefabricated housing and e-commerce. In 2014, Mr. Plaggemars joined Deutsche Balaton AG and founded his own consulting firm, Value Consult, in 2017. In this role, he supports various projects, mainly with a capital market orientation, in different functions and industries.

    Hansjörg Plaggemars holds a degree in business administration from the University of Bamberg.

    Dr. Helge Lubenow, Chairwoman of the Supervisory Board: „We are very pleased that Mr. Plaggemars with his extensive management experience and expertise in finance is joining Epigenomics AG.“

    „I am looking forward to becoming part of the Epigenomics team,“ said Hansjörg Plaggemars.

     

    Contact:
    Company
    Epigenomics AG, Bertha-Benz-Strasse 5, 10557 Berlin
    Tel +49 (0) 30 24345 0, Fax +49 (0) 30 24345 555, Email: contact@epigenomics.com

    Investor Relations
    IR.on AG, Frederic Hilke, Tel +49 221 9140 970, Email: ir@epigenomics.com


    Note on forward-looking statements

    This publication expressly or implicitly contains forward-looking statements concerning Epigenomics AG and its business. These statements involve certain known and unknown risks, uncertainties and other factors that may cause Epigenomics AG's actual results, financial condition and performance to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics makes this announcement as of the date of this release and does not intend to update any forward-looking statements contained herein as a result of new information or future events or otherwise.

     



    31.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: Epigenomics AG
    Bertha-Benz-Straße 5
    10557 Berlin
    Germany
    Phone: +49 30 24345-0
    Fax: +49 30 24345-555
    E-mail: ir@epigenomics.com
    Internet: www.epigenomics.com
    ISIN: DE000A37FT41
    WKN: A37FT4
    Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1827313

     
    End of News EQS News Service

    1827313  31.01.2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1827313&application_name=news&site_id=wallstreet


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board EQS-News: Epigenomics AG / Key word(s): Personnel Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board 31.01.2024 / 15:30 CET/CEST The issuer is solely responsible for the content of …